Related Experiment Video
Updated: May 3, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
The interplay between autophagy and apoptosis in the diabetic heart
Changhan Ouyang1, Jieyun You1, Zhonglin Xie1
1Section of Molecular Medicine, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Insights
Diabetic cardiomyopathy, a complication of diabetes, involves heart dysfunction. This review explores how the interplay between cardiomyocyte apoptosis and suppressed cardiac autophagy contributes to diabetic heart disease progression.
Area of Science:
- Cardiovascular Research
- Metabolic Disease Mechanisms
- Cellular Biology
Background:
- Diabetic cardiomyopathy (DCM) is ventricular dysfunction in diabetic patients, unrelated to other cardiovascular conditions.
- DCM is a significant contributor to mortality in individuals with diabetes.
- Understanding the pathogenesis of DCM is crucial for developing effective treatments.
Purpose of the Study:
- To review recent advances in the understanding of diabetic cardiomyopathy.
- To elucidate the critical role of the interplay between apoptosis and autophagy in DCM pathogenesis.
- To highlight the importance of protein quality control in diabetic cardiac dysfunction.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of emerging evidence on cellular pathways in diabetic cardiomyopathy.
- Focus on the interaction between autophagy and apoptosis in cardiomyocytes.
Main Results:
- Diabetes mellitus induces cardiomyocyte apoptosis (programmed cell death).
- Diabetes suppresses cardiac autophagy, a cellular degradation process.
- The crosstalk between apoptotic and autophagic pathways is central to DCM development.
Conclusions:
- The interaction between cardiomyocyte apoptosis and suppressed autophagy is a key mechanism in diabetic cardiomyopathy.
- Targeting these pathways may offer therapeutic strategies for diabetic heart disease.
- Further research into protein quality control mechanisms is warranted for DCM.
Abstract:
Diabetic cardiomyopathy is characterized by ventricular dysfunction that occurs in diabetic patients independent of coronary artery disease, hypertension, and any other cardiovascular diseases. Diabetic cardiomyopathy has become a major cause of diabetes-related mortality. Thus, an urgent need exists to clarify the mechanism of pathogenesis. Emerging evidence demonstrates that diabetes induces cardiomyocyte apoptosis and suppresses cardiac autophagy, indicating that the interplay between the autophagy and apoptotic cell death pathways is important in the pathogenesis of diabetic cardiomyopathy. This review highlights recent advances in the crosstalk between autophagy and apoptosis and its importance in the development of diabetic cardiomyopathy. This article is part of a Special Issue entitled "Protein Quality Control, the Ubiquitin Proteasome System, and Autophagy".
Related Concept Videos
Cellular Injury V: Apoptosis and Autophagy
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Apoptosis
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Pathophysiology of Heart Failure

